TargetMol

Ossirene

Product Code:
 
TAR-T6761
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6761-1mg1mg£98.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6761-5mg5mg£134.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6761-10mg10mg£168.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6761-25mg25mg£225.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6761-50mg50mg£306.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6761-100mg100mg£425.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6761-200mg200mg£592.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
AS101, a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta converting enzyme.
CAS:
106566-58-9
Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.04
Pathway:
Apoptosis; Proteases/Proteasome; Immunology/Inflammation
Purity:
0.98
SMILES:
N.Cl[TeH]1(Cl)(Cl)OCCO1
Target:
IL Receptor; Caspase; Interleukin

References

Brodsky M, et al. J Interferon Cytokine Res. 2007, 27(6):453-62. Wei Wei,Jia Li,Fan Liu, et al. Alteration of intestinal microecology by oral antibiotics promotes oral squamous cell carcinoma development. Molecular Immunology. 2022 Jul 6;149:94-106 Halperin-Sheinfeld M, et al. Aging (Albany NY). 2012, 4(6):436-47.